.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

GLIMEPIRIDE - Generic Drug Details

« Back to Dashboard
Glimepiride is the generic ingredient in six branded drugs marketed by Teva, Carlsbad, Indoco Remedies, Micro Labs Ltd India, Mylan, Hikma Pharms, Aurobindo Pharma Ltd, Ranbaxy, Vintage, Corepharma, Ranbaxy Labs Ltd, Watson Labs, Accord Hlthcare, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, Invagen Pharms, Sanofi Aventis Us, Takeda Pharms Usa, Sandoz, Sb Pharmco, and Teva Pharms Usa, and is included in twenty-two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for glimepiride. Forty-two suppliers are listed for this compound.

Summary for Generic Name: GLIMEPIRIDE

Tradenames:6
Patents:8
Applicants:21
NDAs:22
Drug Master File Entries: see list14
Suppliers / Packaging: see list42
Therapeutic Class:Blood Glucose Regulators
Drug Prices:see low prices

Pharmacology for Ingredient: GLIMEPIRIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

Clinical Trials for: GLIMEPIRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa
DUETACT
glimepiride; pioglitazone hydrochloride
TABLET;ORAL021925-002Jul 28, 2006RXNo7,700,128Jan 30, 2027Y
Watson Labs
GLIMEPIRIDE
glimepiride
TABLET;ORAL077280-003Feb 3, 2006DISCNNo
Dr Reddys Labs Ltd
GLIMEPIRIDE
glimepiride
TABLET;ORAL077091-002Oct 6, 2005RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: glimepiride

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
AMARYL
glimepiride
TABLET;ORAL020496-001Nov 30, 19954,379,785*PED<disabled>
Sanofi Aventis Us
AMARYL
glimepiride
TABLET;ORAL020496-003Nov 30, 19954,379,785*PED<disabled>
Sanofi Aventis Us
AMARYL
glimepiride
TABLET;ORAL020496-002Nov 30, 19954,379,785*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc